SUPRAME - ACTENGINE IMA203 VS. INVESTIGATOR'S CHOICE OF TREATMENT IN PREVIOUSLY TREATED, UNRESECTABLE OR METASTATIC CUTANEOUS MELANOMA

Registry ID

IMA203 301

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

IMMATICS US, INC.

Start date

2026-01-02

Last update

2025-11-14

Conditions

• CUTANEOUS MELANOMA

View on source registry